PBSC autotransplant for inflammatory bowel disease (IBD): A case of ulcerative colitis [1]

Bone Marrow Transplantation

Volumn 28, Issue 1, 2001, Pages 109-110

  Marti J L ^a   Mayordomo, J I ^a   Isla, M D ^a   Saenz, A ^a   Escudero, P ^a   Tres, A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CARBOPLATIN; CD34 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; MESALAZINE; THIOTEPA;

ADULT; AUTOTRANSPLANTATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CASE REPORT; COLON BIOPSY; COLONOSCOPY; ENTERITIS; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKOCYTE COUNT; MASTECTOMY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RELAPSE; STEM CELL TRANSPLANTATION; ULCERATIVE COLITIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CD4-CD8 RATIO; COLITIS, ULCERATIVE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034903908     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703103     Document Type: Letter

References (7)

1. Crohn's disease complicated by relapsed extranodal Hodgkin's lymphoma: Prolonged complete remission after unmanipulated PBPC autotransplant
2. Hematopoietic stem cell transplant for autoimmune disease
3. Prolonged clinical remission in patients with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation
4. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
5. Stem cell transplantation for inflammatory bowel disease: Practical and ethical issues
6. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease
7. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease